US Study Shows How to Avert Dementia After Age 60
Lifestyle changes including exercise, a better diet, and more mental and social activity yielded significant protection within two years, according to a large clinical trial published Monday. To qualify for the study, participants had to have various risk factors for brain decline, like consuming a poor diet and not exercising regularly. Others had a gene mutation tied to Alzheimer's disease.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Dionysus Health and Mammha Announce Groundbreaking Partnership to Transform Postpartum Depression Care Through Precision Diagnostics and Comprehensive Support
SAN DIEGO, CA - July 30, 2025 (NEWMEDIAWIRE) - Dionysus Health, the molecular diagnostics company behind myLuma(TM), and Mammha, a leading provider of accessible, full-spectrum perinatal mental health care, today announced a groundbreaking partnership to fundamentally reshape how postpartum depression (PPD) is predicted, prevented, and treated. This first-of-its-kind collaboration combines myLuma(TM) - the first predictive prenatal blood test for postpartum depression risk - with Mammha's clinician-designed care platform, delivering the most complete and proactive maternal mental health solution on the market. myLuma(TM) is the first clinically validated molecular diagnostic that predicts a woman's risk of PPD with 85% accuracy from a simple third-trimester blood draw. This allows providers to intervene as early as 28 weeks into pregnancy - weeks to months before symptoms may appear. Combined with Mammha's full continuum of care, the partnership ensures mothers are not only identified early but supported throughout their entire maternal journey. "This partnership brings together scientific innovation and clinical care to deliver a true end-to-end solution," said Dr. Andrea Cubitt, CEO of Dionysus Health. "myLuma(TM) provides the critical early warning system through molecular diagnostics, while Mammha ensures timely care delivery. We're moving from reactive treatment to proactive prevention, from uncertainty to precision, and from fragmented efforts to coordinated care." "We created Mammha to fill the gaps in the perinatal healthcare system that parents have been falling through for much too long," said Maureen Fura, CEO of Mammha. "Partnering with Dionysus Health gives us the predictive power we've always dreamed of having, so that we can intervene early and effectively." Why This Matters Now Postpartum depression is one of the most urgent and preventable maternal health crises: PPD contributes to almost 1 in 4 maternal deaths 75% of affected women receive no treatment The U.S. spends over $17 billion annually addressing the consequences 96% of U.S. counties face mental health provider shortages Only 33% of providers screen for perinatal depression (HEDIS) "We're solving for OB providers, health systems, and mothers," said Alisa Marie Beyer, COO of Dionysus Health. "While screening tools remain essential for identifying current symptoms, until now there's been no biological diagnostic for PPD to predict risk before symptoms emerge. This partnership brings predictive data and enhanced support tools to enable proactive prevention, earlier intervention, and better outcomes for everyone involved." Next Steps for Launch and Growth The integrated myLuma solution is projected to kick-off in September 2025 with a pilot program involving multiple OB providers across California and Florida, aiming for 100 completed patient tests per month. It is anticipated to grow the pilot to an additional 50 OB providers. The full-scale launch is planned for January 2026, targeting 100 provider offices and serving over 1,000 women monthly. Dionysus Health is currently managing a growing waitlist of providers and patients ahead of the national rollout. About Dionysus Health is a molecular diagnostics company focused on maternal mental health breakthroughs. The company developed MyLuma(TM), the first prenatal blood test that predicts postpartum depression risk with 85% accuracy, enabling personalized treatment and support for every mother. Dionysus Health's mission is to replace delayed, self-reported screenings with clinically validated diagnostics that deliver reliable, early insights for patients, providers, and health systems. Mahmma is on a mission to provide a comprehensive, accessible perinatal mental health solution. Created by clinicians and parents, Mahmma serves as the go-to solution for providers, health systems, hospitals, and NICUs to screen, refer, support, educate, and treat pregnant and postpartum women experiencing maternal mental health complications like depression and anxiety, and their families. Media Contact Full Name: Amy VanHaren Company Name: Dionysus Health Email: avanharen@ Phone Number: 6513038777 Website: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
Fact Check: Digging into claim Bill Gates got approval to 'secretly' spray RNA on crops
Claim: Tech billionaire investor Bill Gates was given approval to "secretly" spray synthetic RNA on food products in the United States through a company called Terrana Biosciences. Rating: In late July 2025, a rumor spread widely across social media platforms that billionaire investor Bill Gates received approval to "secretly" spray synthetic RNA on food crops in the United States. One Facebook post (archived) with the claim amassed over 69,000 reactions, 38,800 comments and 56,000 shares. It included images of Gates in a crop field, a close-up of him holding a vial and illustrations of mRNA vaccine mechanisms alongside visuals of planes and tractors spraying farmland. According to the post, Gates had received "approval to 'secretly' spray RNA on food products in the United States" through a new venture called Terrana Biosciences. The post further claimed that RNA would "fundamentally reprogram" crops' biology and concluded with a line reading, "Critics are now RNA can be dispersed on crops under the cover of eco-friendliness, what's preventing its hidden application on humans for 'supposed' disease control?" Users made similar claims on X and Instagram. One X post (archived) alleged that Gates was "poisoning food" after "poisoning humanity by way of bioweapons." Another (archived) stated, "Bill Gates, through his backing of Flagship Pioneering, has been given the green light to secretly spray synthetic RNA on America's food products." These claims, however, were false. There was no credible evidence that Gates has been granted approval, secret or otherwise, to spray RNA (including mRNA, a single-stranded type of RNA) on food crops in the United States. The company at the center of the rumor, Terrana Biosciences, is a newly launched agricultural venture backed by the venture capital firm Flagship Pioneering. At the time of this writing, Terrana was exploring RNA-based crop protection technology — but the company was still in the research and development phase and none of its products was approved for commercial use. There was no indication that Terrana's products were being deployed in July 2025, nor that they posed a health risk to humans. A spokesperson for Flagship confirmed over email that neither Bill Gates nor the Bill & Melinda Gates Foundation had any financial, advisory or operational involvement with Terrana Biosciences. The organization also emphasized that any future products would be subject to review by the relevant U.S. regulatory agencies before entering the market. How the rumor spread The rumor appeared to have originated from a July 26 article (archived) from The People's Voice — a rebranded version of NewsPunch, a website with a long history of publishing false information. The article, titled, "Bill Gates Given Green Light to Secretly Spray RNA on Food Products in America," asserted without citing any sources that Gates backed Terrana through Flagship Pioneering and was preparing to "infiltrate crops" with synthetic RNA "without public consent or oversight." Screenshots of the article quickly circulated on social media. However, no credible sources supported the notion that Gates was involved in Terrana Biosciences or that RNA products were being "secretly" deployed on crops. Claims that the technology was intended to "poison food" were also entirely unfounded. What Terrana Biosciences is actually doing Terrana Biosciences was publicly launched in early July 2025 by Flagship Pioneering, which also helped incubate the pharmaceutical and biotech company Moderna. That connection likely fueled speculation linking the company to mRNA vaccines, though Terrana's work is entirely unrelated to human medicine. According to Terrana's own press release, the company is developing RNA-based agricultural solutions focused on "enhancing crop resilience, protecting yields and addressing critical challenges in the global food system." In an interview with AgFunder News, Terrana CEO Jeremy Rapp compared the technology to a "programmable vaccine" for plants, explaining that "after being sprayed on, the RNA enters the plant through small tears in the leaves." While Terrana is designing its platform to work alongside existing chemical and biological crop protection products, Rapp said the long-term goal is to help farmers "reduce their reliance on chemistry in the future." As of July 2025, Terrana's products remained in the development and testing phase. There was no record of approval from the regulatory agencies and no evidence that any of the company's products were being used commercially or deployed at scale. Gates Foundation and Flagship Pioneering The rumor that Gates was behind Terrana likely stemmed from the fact that the Bill & Melinda Gates Foundation awarded two grants in 2024 to Flagship Pioneering companies for unrelated research. One of those companies was Sail Biomedicines, which was also developing an RNA-based solution for malaria prevention. There was no evidence connecting the Gates Foundation's support to Terrana Biosciences nor any indication that Gates personally backed or approved RNA spraying projects involving food crops. A spokesperson for Flagship Pioneering also explicitly denied these claims. All in all, there was no evidence that Gates had been granted approval to "secretly" spray RNA on crops in the United States or that he had any involvement in Terrana Biosciences. The company's RNA-based solutions remain in development and have not been authorized for commercial use. Notably, Gates was the subject of similar rumors in the past, some of which The People's Voice also spread. In May 2023 we debunked a related false rumor claiming mRNA from COVID-19 vaccines had entered the food supply via genetically modified plants bred to contain it or through the consumption of vaccinated livestock. Adl-Tabatabai, Sean. "Bill Gates Given Green Light to Secretly Spray RNA on Food Products in America." The People's Voice, 26 Jul. 2025, Binder, Matt. "Fake News Sites Are Simply Changing Their Domain Name to Get around Facebook Fact-Checkers." Mashable, 31 Jan. 2019, "FACT FOCUS: COVID Vaccines Are Not in the Food Supply." AP News, 25 Apr. 2023, Kasprak, Alex. "Has Vaccine mRNA Entered the Food Supply via GMO Plants or Vaccinated Livestock?" Snopes, 3 May 2023, Marston, Jennifer. "Flagship Pioneering's New RNA-Based Crop Protection Company Could Provide 'a Huge Way to Deal with Climate Change.'" AgFunderNews, 2 Jul. 2025, "Moderna Timeline." Flagship Pioneering, Accessed 30 Jul. 2025. "No, an 'Air Vaccine' Tied to Bill Gates Was Not Approved for Use on Non-Consenting People." AP News, 11 Oct. 2023, Terrana Biosciences. Accessed 30 Jul. 2025. ---. Accessed 30 Jul. 2025. Accessed 30 Jul. 2025.
CBS News
23 minutes ago
- CBS News
Lawsuit alleges Hormel Foods denied workers earned safe and sick time
Workers are suing Minnesota-based Hormel Foods, alleging the food giant does not allow employees to take paid time off if they get sick. The class action lawsuit alleges Hormel violated the Minnesota Earned Safe and Sick Time law for UFCW Local 663 members. The union represents more than 1,600 meatpacking workers at Hormel's Austin, Minnesota, plant. The lawsuit claims workers had to use vacation days instead of sick days if they wanted to get paid for the time off. Hormel is accused of refusing to provide employees with earned sick and safe time (ESST) benefit accruals for their work between Jan. 1, 2024, and March 1, 2025, and denying the workers' statutory right to carry over their accrued, unused ESST benefits into the 2025 calendar year. The lawsuit also alleges Hormel failed to give "all or most" employees any of the ESST benefits they earned in January and February this year, "Workers, advocates, and legislators fought hard to make Earned Sick and Safe Time law. Now, ESST is a statewide standard," said UFCW Local 663 President Rena Wong. "UFCW 663 members know what it means to fight for what we deserve and win. After all, workers at Hormel set the standard for wages in the meatpacking industry." Hormel declined to comment. The lawsuit is the first of its kind since the law passed in 2023, according to the Minnesota Senate DFL. Under the law, anyone is eligible for the sick and safe time if they work 80 hours a year and don't qualify as an independent contractor. The policy approved by the DFL-led legislature allows people to use the time for treating mental or physical illness, going to medical appointments, caring for a family member who's ill, and even due to inclement weather that may close children's school and keep them home. It also covers absences related to domestic abuse or sexual assault. "As chief author of the 2023 Earned Sick and Safe Time law, I am proud to stand with the workers of UFCW Local 663 as they demand the rights they are due," Sen. Sandra Pappas, DFL-St. Paul, said. "Hormel must follow Minnesota law and stop disrespecting its workers. I look forward to UFCW Local 663's day in court." There's a long history of labor activism at the Hormel plant in Austin. In the mid-1980s, about 1,500 workers went on strike for 13 months in one of the longest strikes in state history. The employees cited a wage freeze, dangerous working conditions and a wage cut as the reason for the Cummings contributed to this report.
